FDA advisory committee recommends Pfizer-BioNTech COVID-19 booster for older adults, high-risk and high-exposure groups
On 2021-10-14, the FDA's Vaccines and Related Biological Products Advisory Committee voted to recommend booster doses of the Pfizer-BioNTech COVID-19 vaccine for people 65 and older, residents of long-term care facilities, and individuals at high risk of severe disease or high occupational exposure.